FTD Global Study Locator

Nov 20 - 2012 10:00 AM
Read more

CNS Leaders Forum - Boston

Nov 08 - 2012 04:00 AM
Professor Claude Wischik found that the underlying pathology of Alzheimer’s known as Tau tangles is present in the brain up to 30 years before clinical symptoms develop and that the presence of this pathology is highly correlated with disease progression.
Read more

Phase 3 clinical trial begins in mild to moderate Alzheimer's Disease

Oct 30 - 2012 06:03 PM
Phase 3 clinical trial begins in mild to moderate Alzheimer's Disease with a second-generation Tau Aggregation Inhibitor (TAI) aimed at halting the progression of Alzheimer's.
Read more

Phase 3 clinical trial begins in FTD, an early form of dementia

Sep 28 - 2012 11:00 PM
Phase 3 clinical trial begins in early form of dementia
Read more

US patent granted: Patent for TauRx’s next generation Tau Aggregation Inhibitor

Sep 30 - 2011 06:57 AM
US patent granted: Patent for TauRx’s next generation Tau Aggregation Inhibitor compound granted extensively
Read more